Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DOCETAXEL\DOCETAXEL ANHYDROUS for Angiosarcoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 9 adverse event reports in the FDA FAERS database where DOCETAXEL\DOCETAXEL ANHYDROUS was used for Angiosarcoma.

Most Reported Side Effects for DOCETAXEL\DOCETAXEL ANHYDROUS

Side Effect Reports % Deaths Hosp.
Diarrhoea 409 10.7% 129 195
Myelosuppression 404 10.6% 10 246
Disease progression 289 7.6% 65 46
Off label use 281 7.3% 51 115
Nausea 279 7.3% 92 104
Neutropenia 250 6.5% 46 85
Fatigue 236 6.2% 107 73
Pyrexia 221 5.8% 75 109
Vomiting 216 5.6% 79 93
Asthenia 190 5.0% 71 59
Anaemia 188 4.9% 29 79
Drug ineffective 184 4.8% 39 42
Decreased appetite 172 4.5% 74 53
Dyspnoea 162 4.2% 82 39
Febrile neutropenia 155 4.1% 40 91

Other Indications for DOCETAXEL\DOCETAXEL ANHYDROUS

Breast cancer (791) Product used for unknown indication (388) Her2 positive breast cancer (216) Breast cancer metastatic (200) Prostate cancer (182) Breast cancer female (159) Invasive ductal breast carcinoma (149) Prostate cancer metastatic (116) Lung adenocarcinoma (114) Chemotherapy (107)

Other Drugs Used for Angiosarcoma

PAZOPANIB (164) PACLITAXEL (148) DOXORUBICIN (126) DOCETAXEL (94) GEMCITABINE (67) SIROLIMUS (59) IFOSFAMIDE (53) NIVOLUMAB (46) PEMBROLIZUMAB (37) BEVACIZUMAB (36)

Related Pages

DOCETAXEL\DOCETAXEL ANHYDROUS Full Profile All Angiosarcoma Drugs DOCETAXEL\DOCETAXEL ANHYDROUS Demographics DOCETAXEL\DOCETAXEL ANHYDROUS Timeline